Mackenzie Financial’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.56M Buy
106,900
+25,509
+31% +$1.84M 0.01% 730
2026
Q2
$6.08M Buy
+81,391
New +$5.86M 0.01% 785
2025
Q4
– Sell
-15,737
Closed -$869K – 1768
2025
Q3
$869K Sell
15,737
-640
-4% -$33.3K ﹤0.01% 1104
2025
Q2
$706K Sell
16,377
-455
-3% -$17.6K ﹤0.01% 1114
2025
Q1
$666K Buy
16,832
+1,040
+7% +$46K ﹤0.01% 1104
2024
Q4
$644K Buy
+15,792
New +$658K ﹤0.01% 1071
2024
Q3
– Sell
-7,753
Closed -$339K – 1650
2024
Q2
$339K Buy
7,753
+3,356
+76% +$162K ﹤0.01% 1116
2024
Q1
$210K Hold
4,397
– – ﹤0.01% 1328
2023
Q4
$208K Buy
+4,397
New +$183K ﹤0.01% 1318
2023
Q3
– Sell
-4,311
Closed -$253K – 1547
2023
Q2
$253K Sell
4,311
-533
-11% -$32K ﹤0.01% 1237
2023
Q1
$346K Buy
4,844
+588
+14% +$46.7K ﹤0.01% 1136
2022
Q4
$300K Buy
+4,256
New +$300K ﹤0.01% 1091
2017
Q2
– Sell
-5,900
Closed -$359K – 651
2017
Q1
$359K Buy
+5,900
New +$334K ﹤0.01% 557

Other funds holding NGVT

Mackenzie Financial's NGVT Position: Q3 2026 in Review

Mackenzie Financial increased its Ingevity (NGVT) stake by 31% in Q3 2026, buying an estimated $1.84M and bringing the position to 106,900 shares worth $7.56M. The position accounts for 0.01% of the portfolio, ranked #730.

Mackenzie Financial first reported a position in NGVT in Q1 2017 and has held it in 13 quarters since. 109 funds tracked by Wall St. Rank hold NGVT as of Q3 2026.

  • Mackenzie Financial held 106,900 shares of Ingevity worth $7.56M as of Q3 2026.
  • Mackenzie Financial bought 25,509 Ingevity shares in Q3 2026, an estimated $1.84M.
  • Ingevity made up 0.01% of Mackenzie Financial's portfolio in Q3 2026, its #730 holding.
  • Mackenzie Financial first reported a position in Ingevity in Q1 2017 and has held it in 13 quarters since.
  • 109 funds tracked by Wall St. Rank held Ingevity as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.